BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6420108)

  • 41. Lambda Light Chain Non-crystalline Proximal Tubulopathy with IgD Lambda Myeloma.
    Kishi S; Obata F; Miki H; Matsuura M; Nishimura K; Tamaki M; Kishi F; Murakami T; Abe H; Nagai K; Abe M; Doi T
    Intern Med; 2018 Dec; 57(24):3597-3602. PubMed ID: 30101939
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical and prognostic differences among patients with light chain deposition disease, myeloma cast nephropathy and both.
    Zand L; Nasr SH; Gertz MA; Dispenzieri A; Lacy MQ; Buadi FK; Kumar S; Kyle RA; Fervenza FC; Sethi S; Dingli D; Rajkumar SV; Kapoor P; McCurdy A; Leung N
    Leuk Lymphoma; 2015; 56(12):3357-64. PubMed ID: 25860232
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Plasma cell myeloma, hyperviscosity and amyloidosis associated with a serum IgG3 lambda and urinary excretion of two fragments related to the variable portion of lambda light chains.
    Isobe T; Takatsuki K; Tishendorf FW; Birken S; Osserman EF
    Clin Immunol Immunopathol; 1981 Apr; 19(1):55-66. PubMed ID: 6783356
    [No Abstract]   [Full Text] [Related]  

  • 44. IgA myeloma in a patient with diabetes mellitus and hypertension: case report.
    Ezeoke AC; Udeozo IO; Ikeh VO
    East Afr Med J; 1985 Jul; 62(7):466-9. PubMed ID: 3935409
    [No Abstract]   [Full Text] [Related]  

  • 45. [Light chain myeloma: clinical study and prognostic factors ].
    Redón J; Caballero M; Herranz C
    Med Clin (Barc); 1982 Jun 16-30; 79(2):54-8. PubMed ID: 6811809
    [No Abstract]   [Full Text] [Related]  

  • 46. Light chain crystalline kidney disease: diagnostic urine microscopy as the "liquid kidney biopsy".
    Luciano RL; Castano E; Fogazzi GB; Perazella MA
    Clin Nephrol; 2014 Dec; 82(6):387-91. PubMed ID: 25295579
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Renal monoclonal immunoglobuline deposition disease as a rare variant of renal damage in multiple myeloma].
    Gorchakova SV; Rekhtina IG; Iatskov KV; Sukhanova GA; Golitsina EP; Varshavskiĭ VA; Biriukova LS
    Ter Arkh; 2009; 81(7):78-82. PubMed ID: 19708580
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Two-dimensional gel electrophoresis as an aid in the analysis of monoclonal gammopathies.
    Tracy RP; Kyle RA; Young DS
    Hum Pathol; 1984 Feb; 15(2):122-9. PubMed ID: 6421714
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Proximal tubular injury in myeloma.
    Batuman V
    Contrib Nephrol; 2007; 153():87-104. PubMed ID: 17075225
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Protease resistance and binding of Ig light chains in myeloma-associated tubulopathies.
    Leboulleux M; Lelongt B; Mougenot B; Touchard G; Makdassi R; Rocca A; Noel LH; Ronco PM; Aucouturier P
    Kidney Int; 1995 Jul; 48(1):72-9. PubMed ID: 7564094
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Complete amino acid sequence of a unique protein related to the variable domain of lambda light chain from a case with Fanconi syndrome.
    Kametani F; Yoshimura K; Tonoike H; Hoshi A; Shinoda T; Isobe T
    Biochem Biophys Res Commun; 1985 Jan; 126(2):848-52. PubMed ID: 3919718
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Unexpected migration of free light chains in urinary protein electrophoresis.
    Nel I; Thiolières JM; Ghillani-Dalbin P; Jacquiaud C; Piéroni L
    Ann Biol Clin (Paris); 2017 Feb; 75(1):75-82. PubMed ID: 27976610
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Kappa light chain glomerulosclerosis in multiple myeloma.
    Seymour AE; Thompson AJ; Smith PS; Woodroffe AJ; Clarkson AR
    Am J Pathol; 1980 Dec; 101(3):557-80. PubMed ID: 6778218
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Two cases of IgD (K-type) myeloma--with special reference to urine protein analyses (author's transl)].
    Nakazawa O; Niitsu Y; Katayama S; Koyama R; Gocho Y
    Rinsho Ketsueki; 1975 Oct; 16(10):963-71. PubMed ID: 813021
    [No Abstract]   [Full Text] [Related]  

  • 55. [Improved prognosis in light chain nephropathy due to multiple myeloma].
    Juul JS; Larsen T; Marcussen N; Pedersen EB
    Ugeskr Laeger; 2012 Apr; 174(17):1159-60. PubMed ID: 22533933
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Free immunoglobulin L chains].
    Numata Y
    Rinsho Byori; 1983 May; 31(5):489-95. PubMed ID: 6415322
    [No Abstract]   [Full Text] [Related]  

  • 57. [Myeloma and the kidney].
    Linnanvuo-Laitinen M; Huttunen K; Timonen T
    Duodecim; 1987; 103(1):42-6. PubMed ID: 3111820
    [No Abstract]   [Full Text] [Related]  

  • 58. [Determination of free kappa and lambda light chains in urine by immunoenzyme analysis].
    León VJ; León E; Martínez-Pescador R; López-Borrasca A
    Sangre (Barc); 1986; 31(3):311-6. PubMed ID: 3092374
    [No Abstract]   [Full Text] [Related]  

  • 59. Monoclonal immunoglobulin deposition disease: light chain and light and heavy chain deposition diseases and their relation to light chain amyloidosis. Clinical features, immunopathology, and molecular analysis.
    Buxbaum JN; Chuba JV; Hellman GC; Solomon A; Gallo GR
    Ann Intern Med; 1990 Mar; 112(6):455-64. PubMed ID: 2106817
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Urinary proteins in multiple myeloma: correlation with clinical parameters and diagnostic implications.
    Corso A; Zappasodi P; Pascutto C; Bosoni T; Mangiacavalli S; Lorenzi A; Rusconi C; Lazzarino M
    Ann Hematol; 2003 Aug; 82(8):487-491. PubMed ID: 12838370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.